Berlex, Inc., a U.S. affiliate of Bayer Schering Pharma AG, Germany, announced today the results of a retrospective study
From: biz.yahoo.com
Large Study Shows that Presence of Neutralizing Antibodies Did Not Predict Clinical Response to Betaseron Treatment
Posted by Ruslan Abuzant at 6:31 AM
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment